Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Biol Trace Elem Res. 2013 Oct 6;156(0):210–220. doi: 10.1007/s12011-013-9820-7

Table 1.

Bone Mineral Density in femora and vertebrae.

Diet group Femoral BMD (mg/cc)
5-months 12-months 18 months
Trabecular
Baseline 174 ± 18
Control 156 ± 12* 131 ± 21* 120 ± 38*
Control + minerals 234 ± 15c 158 ± 35 142 ± 40
HFWD 164 ± 54 146 ± 11* 79 ± 29*
HFWD + minerals 201 ± 11a, b 171 ± 18a, b 143 ± 30a
Cortical
Baseline 151 ± 6
Control 347 ± 16 309 ± 36 303 ± 27
Control + minerals 378 ± 25c 302 ± 31 299 ± 28
HFWD 314 ± 36 287 ± 30 260 ± 34
HFWD + minerals 339 ± 16 322 ± 21 322 ± 47a
Vertebral BMD (mg/cc)
12-months 18 months
Trabecular
Control 619 ± 63 Not done
Control + minerals 737 ± 83c Not done
HFWD 482 ± 34 452 ± 46
HFWD + minerals 687 ± 107a 659 ± 108a
Cortical
Control 961 ± 30 Not done
Control + minerals 942 ± 14 Not done
HFWD 731 ± 25 763 ± 146
HFWD + minerals 941 ± 33a 928 ± 43

Femoral data are based on 5 mice at baseline (3 weeks of age), 10 mice at 5 and 12 months and 15 mice at 18 months in each diet group. Vertebral data are based on 6 mice at 12 months in each diet group and 6 mice in each of the two high-fat diets at 18 months. Values are means and standard deviations. Statistical significance was determined by ANOVA followed by paired group comparisons. “*” are placed to show the statistically significant drop in the BMD relative to baseline. “a” and “b” are placed on the HFWD+minerals group: “a” shows statistically significant increase relative to the HFWD group, “b” shows statistically significant increase relative to control; “c” is placed on the control+minerals group, and shows significant increase relative to the control (p <0.05). Data from baseline and 5 months in all groups and in control diets at 18 months for the vertebrae are not available.